Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1990-02-08
1991-11-19
Chan, Nicky
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
562430, A61K 3119, C07C31714
Patent
active
050666762
ABSTRACT:
The xanthosulfonamido and benzensulfonamido derivatives corresponding to the formula: ##STR1## wherein X represents hydrogen, alkyl, alkoxy or halogen, Y represents an alkyl, alkoxy or halogen and Z represents the group ##STR2## or Y and Z taken together form the group: ##STR3## wherein R.sub.1 in turn is a group selected among electron attracting groups, halogens and the group: ##STR4## itself, possess activity in inhibiting the aldose-reductase enzyme system and are thus useful in the treatment of the complications, at the eye and peripheral neuropathy levels, as induced by diabetes.
REFERENCES:
patent: 4113463 (1978-09-01), Oshio et al.
Baldacci Massimo
Caccia Giulio
Chan Nicky
Laboratori Baldacci SpA
LandOfFree
Sulfonamido derivative inhibiting the aldose reductase enzyme sy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfonamido derivative inhibiting the aldose reductase enzyme sy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonamido derivative inhibiting the aldose reductase enzyme sy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1370631